GLYCOMIMETICS INC

Profile

Company Names

GLYCOMIMETICS INC

Addresses

101 ORCHARD RIDGE DRIVE, SUITE 1E, GAITHERSBURG, MD 20878

Phone Numbers

240-243-1201

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$54,294,937.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2009-10-20 
$38,979,412.00 
$50,000,000.00 
$11,020,588.00 
Equity 
1
2008-07-03 
$15,315,525.00 
$15,315,525.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
BALDWIN 
DIRECTOR
GLYCOMIMETICS INC   |  CASTLEWOOD SURGICAL INC   |  PCF 1, LLC
M. 
JAMES 
BARRETT 
DIRECTOR
NEW ENTERPRISE ASSOCIATES 13 LP   |  GLYCOMIMETICS INC   |  SENSORS FOR MEDICINE + SCIENCE INC   |  NEW ENTERPRISE ASSOCIATES 14, L.P.   |  ZOSANO, INC.   |  ZP HOLDINGS INC   |  SENSEONICS, INC   |  ZOSANO PHARMA CORP   |  PROTEOSTASIS THERAPEUTICS, INC.   |  SENSEONICS HOLDINGS, INC.
WILLIAM 
 
GUST 
DIRECTOR
GLYCOMIMETICS INC   |  NEODIAGNOSTIX INC
MICHAEL 
 
HENOS 
DIRECTOR
GLYCOMIMETICS INC   |  INHIBITEX, INC.
RACHEL 
 
KING 
EXECUTIVE OFFICER, DIRECTOR
GLYCOMIMETICS INC
JOHN 
 
MAGNANI 
EXECUTIVE OFFICER, DIRECTOR
GLYCOMIMETICS INC
HELEN 
 
THACKRAY 
EXECUTIVE OFFICER
GLYCOMIMETICS INC
FRANKLIN 
 
TOP 
DIRECTOR
GLYCOMIMETICS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-10-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-20 
2009-11-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2008-07-03 
2009-11-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#